The production of variation in adipose tissue accretion represents a key fetal adaptation to energy substrate availability during gestation. Because umbilical venous blood transports nutrient substrate from the maternal to the fetal compartment and because the fetal liver is the primary organ in which nutrient interconversion occurs, it has been proposed that variations in the relative distribution of umbilical venous blood flow shunting either through ductus venosus or perfusing the fetal liver represents a mechanism underlying this adaptation. OBJECTIVE: The objective of the present study was to determine whether fetal liver blood flow assessed before the period of maximal fetal fat deposition (ie, the third trimester of gestation) is prospectively associated with newborn adiposity. STUDY DESIGN: A prospective study was conducted in a cohort of 62 uncomplicated singleton pregnancies. Fetal ultrasonography was performed at 30 weeks gestation for conventional fetal biometry and characterization of fetal liver blood flow (quantified by subtracting ductus venosus flow from umbilical vein flow). Newborn body fat percentage was quantified by dual energy X-ray absorptiometry imaging at 25.8 AE 3.3 (mean AE standard error of the mean) postnatal days. Multiple regression analysis was used to determine the proportion of variation in newborn body fat percentage explained by fetal liver blood flow. Potential confounding
T he deleterious consequences of childhood obesity are well established. 1, 2 Newborn infants exhibit substantial variation in fat mass accretion over gestation. 3 This interindividual difference has been shown to track across infancy into childhood and to relate to future risk of obesity and metabolic dysfunction. [4] [5] [6] Moreover, once established, obesity is extremely difficult to reverse, which highlights the critical importance of primary prevention. 7 Based on the convergence of a large body of epidemiologic, clinical, and experimental evidence in humans and animals, it is increasingly apparent that the origins of obesity (adiposity) can be traced, in part, back to developmental processes during intrauterine life [8] [9] [10] (ie, the concept of the fetal origins of health and disease). 11, 12 The elucidation of the determinants, underlying mechanisms, and biomarkers of fetal programming of obesity and metabolic dysfunction represents an area of active investigation. [13] [14] [15] Broadly, it appears that there are 2 pathways that link intrauterine conditions to increased newborn (and subsequent infant and child) adiposity. The first, a passive process, is a direct consequence of over-nutrition and the availability of excess energy substrate, a scenario most commonly associated with maternal obesity. 16, 17 The second, an active process, represents a fetal adaptation to energy substrate insufficiency. The fetus exhibits a wide array of structural and functional adaptations in response to intrauterine conditions (ie, the concept of developmental plasticity). 18 Among these, variation in energy substrate availability (oxygen and other essential nutrients) represents a condition of particular salience, and variation in fat mass accretion represents an adaptation of considerable importance. When oxygen is limited, fetal adaptations prioritize brain growth, irrespective of whether other essential nutrients are limited. 19, 20 However, when oxygen is adequate, but other essential nutrients are limited, fetal adaptations prioritize adipose tissue accretion, 21, 22 presumably because adipose tissue constitutes a key buffer against limited nutrient supply, particularly to meet the brain's energy requirements during early postnatal life. 23 Indeed, the infant brain requires and uses approximately 40e60% of the infant's total energy needs, 24 and adipose tissueederived ketone bodies can Original Research ajog.org provide as much as 25% of this requirement. 25 The evolutionary significance of this adaptation likely represents the reason that human infants have substantially higher body fat and also larger brains than other mammals. 23 The fetus is capable of de novo synthesis of various nutrients (fatty acids, triglycerides, amino acids, glycogen) [26] [27] [28] using substrates transported across the placenta and carried in umbilical venous blood to the fetal compartment. The fetal liver is the primary site where this interconversion and de novo synthesis occurs. Under conditions of relative essential nutrient deficiency, one way to ensure the provision of a greater supply of maternally derived nutrient substrate to the fetal liver (relative to other organs) is accomplished by the alteration of the relative proportion of umbilical venous blood flow that shunts through the ductus venosus (DV), vis a vis the amount perfused into the fetal liver. Increased fetal liver blood flow (fLBF) is associated with increased hepatic nutrient synthesis that includes precursors of adipose tissue, such as fatty acids and triglycerides, 21, 22 whereas increased DV shunting (ie, flow away from the liver) is associated with increased blood supply to the brain (the "brain-sparing" effect). Under conditions of relative nutrient excess, such as in the context of maternal overweight/ obesity, the accretion of fetal fat would be expected to be less dependent on hepatic nutrient synthesis (given the higher concentrations among overweight/obese mothers of maternal and fetal lipids and glucose, 16 and increased expression of placental fatty acid transporters 29 ). Therefore, in this scenario, variation in fLBF would be expected to feature less prominently in the process of fetal fat accretion.
Based on this line of reasoning, Godfrey et al 21 have proposed that measures of variation in fLBF may constitute a noninvasive biomarker for the amount of fetal adipose tissue accretion, particularly among pregnancies characterized by the absence of fetal hypoxia and absence of over-nutrition. Currently, there are only a few studies that have addressed this hypothesis, and one of their limitations is that they have assessed fLBF after the majority of fetal fat deposition has already occurred (ie, in late gestation). 30, 31 For these reasons, the primary aim of our study was to determine whether fLBF that is measured before the period of maximal fat deposition (ie, in the early third trimester) is associated prospectively with newborn body composition, specifically newborn body fat percentage. We hypothesized that, among pregnancies in which there is no evidence of fetal hypoxia, variation in fLBF would be associated prospectively with newborn adiposity and the magnitude of this association would be particularly pronounced in nonoverweight/nonobese mothers.
Materials and Methods

Study population
Our study population was comprised of 62 mother-newborn infant dyads from a prospective cohort study of the association of biologic and behavioral processes in human pregnancy with newborn infant, infant, and child health outcomes at the University of California, Irvine, Development, Health and Disease Research Program. These subjects represented the subset from the larger cohort in whom all measures of fLBF and newborn dual energy X-ray absorptiometry (DXA) imaging were available. There were no significant differences between the sociodemographic and the obstetric and birth outcome characteristics of the study population and the larger cohort. Women with a singleton uncomplicated pregnancy were recruited in the late first or early second trimester. Maternal exclusionary criteria were uterine anomalies, preexisting major medical comorbidities, conditions associated with neuroendocrine and immune dysfunction (endocrine, hepatic or renal disorders), use of systemic corticosteroids, smoking, and illicit drug use. Newborn infant exclusionary criteria included congenital malformations, chromosomal abnormalities, major perinatal complications associated with neurologic consequences, and preterm birth at <34 completed weeks gestation. The study protocol was approved by the Institutional Review Board, and written informed consent was obtained from all mothers.
Prenatal ultrasonography
Fetal ultrasonography was performed at approximately 30 weeks gestation for fetal biometry and Doppler velocimetry. Each of the conventional fetal biometry measures were obtained in duplicate and averaged. Per standard clinical criteria, gestational age was confirmed at <16 weeks gestation with the use of an algorithm that combines last menstrual period and fetal biometry. 32 All fetal measurements were performed by the same obstetrician (S.I.) who used a Voluson i (GE Healthcare, Milwaukee, WI), with a transabdominal 4-MHz curved array transducer that included color Doppler and pulsed Doppler (3 MHz) facilities (RAB4-8-RS).
The umbilical vein (UV) and DV were identified either in a sagittal plane or in an oblique plane transecting the fetal upper abdomen. Blood flow (Q) was calculated as Q (milliliter/ minute)¼hÂ(D/2) 2 
ÂTAMX,
where D¼vessel inner diameter (mean of 5e10 measurements), 33 TAMX¼time-averaged maximum velocity (mean of 2 measurements), and h¼spatial blood velocity profile coefficient (UV¼0.5; DV¼0.7). 34 TAMX UV was obtained during a 3-to 5-second period. TAMX DV was calculated as the mean during 3 cardiac cycles. D UV was measured in the straight portion of the intraabdominal UV before hepatic parenchymal branching, and D DV was measured at the inlet of DV as previously described. 21, 35 Intraobserver coefficients of variation for TAMX UV , TAMX DV , D UV , and D DV were 6.8%, 6.6%, 6.4%, and 9.3%, respectively (6.7%, 6.4%, 6.3%, 9.1% with prepregnancy body mass index [ 
Birth outcomes
Gestational age at birth, birthweight, and infant sex were abstracted from the medical record. Birthweight percentile was determined with the use of national norms. 43 
Infant body composition
Newborn body fat percentage was assessed by whole body DXA imaging with the use of a Hologic Discovery scanner (QDR 4500A; Hologic Inc, Bedford, MA) in the pediatric scan mode. 44 Potential measurement issues at birth relate to rapid shifts in fluid volume and body composition that can occur in the weeks after birth. 45 Therefore, newborn DXA scans were performed at approximately 1 month postnatal age. Calibration with the Hologic's anthropomorphic Spine QC Phantom was performed before each scan. Infants lay supine while sleeping, wearing only a disposable diaper and swaddled in a light cotton blanket. Movement artifact could affect DXA image; however, we performed a rescan if the image quality was unsatisfactory because of infant movement. Newborn body fat percentage was calculated from newborn fat mass and lean mass measures with the use of the Hologic Analysis (version 12.1) software.
PpBMI and gestational weight gain (GWG)
PpBMI was calculated with prepregnancy weight (by maternal self-report) Less than, n (%) 10 (16) Equal to, n (%) 18 (29) Greater than, n (%) 34 (55) Gestational weight gain per week, kg/wk a 0.37AE0.13
Parity (primiparous), n (%) 22 (36) a Data are presented as mean AE standard error of the mean. 
Statistical analysis
Pearson product moment correlations were used to assess bivariate first-order associations among continuous variables, and the Student t test or 1-way analysis of variance was used to test group differences. We considered a priori the following potential confounding variables in the relationship between fLBF and newborn body fat percentage: maternal age, parity, ppBMI, GWG/ week, gestational age at birth, infant sex, postnatal age at DXA, and mode of infant feeding. The subset of these variables that were significantly associated in bivariate analysis with newborn body fat percentage were included in subsequent multivariate analyses. First, the association of fLBF at 30 weeks gestation with newborn body composition measured by DXA (fat mass, lean mass, and body fat percentage) was determined with the use of bivariate analysis. This association was also examined in subgroup analysis stratified by maternal ppBMI as nonoverweight/nonobese (ppBMI <25 kg/ m 2 ) or overweight/obese (ppBMI !25 kg/m 2 ). Next, multiple linear regression was used to quantify the association between fLBF and newborn body fat percentage, with adjustment for potential confounding factors. With the same set of covariates, the relative contribution of fLBF in explaining variation in newborn body fat percentage was derived from the partial correlation coefficient in the multiple linear regression models. We repeated all analyses replacing fLBF by fLBF/AC to correct for liver size. All statistical analyses were performed using SPSS software (version 22.0; SPSS Inc, Chicago, IL), with statistical significance determined at P<.05.
Results
The maternal sociodemographic and obstetric characteristics are summarized in Table 1 . Descriptive statistics of the fetal blood flow parameters are shown in Table 2 . TAMX UV , TAMX DV , D UV , D DV , Q UV , and Q DV were consistent with previous reports. 35, 47 Mean UA-PI, MCA-PI, and cerebroplacental ratio were 1.00AE0.02 (mean AE standard error of the mean), 1.89AE0.05, and 1.98AE0.07, respectively. There was no fetus with absent or reversed end-diastolic UA flow or MCA-PI <5th percentile. One fetus was excluded because of low cerebroplacental ratio (<5th percentile). 40 Mean gestational age at birth was 39.5 AE 1.1 weeks (mean AE standard error of the mean), and 53% of newborn infants were male. Mean birthweight was 3458AE21 g, and mean birthweight percentile was 51.2AE3.5%. Mean postnatal age at DXA scan was 25.8AE3.3 days. The mean total mass, fat free mass, and fat mass were 4366AE26 g, 3750AE22 g, and 616AE18
g, respectively. Mean newborn body fat percentage was 13.5AE2.4%, which is consistent with FIGURE 2 Fetal liver blood flow and newborn adiposity stratified by maternal ppBMI Scatterplot shows fetal liver blood flow and newborn body fat percentage stratified by maternal ppBMI. Correlation between fetal liver blood flow and newborn body fat percentage was particularly pronounced with mothers whose prepregnancy body mass index was <25 kg/m 2 (n¼36; r¼0.456; P¼.005) and not with those whose prepregnancy body mass index was !25 kg/m 2 (n¼26; r¼0.229; P¼.261). ajog.org OBSTETRICS Original Research previous reports. 48 At the time of DXA scan, 28 infants were breast-fed; 11 infants were formula-fed, and 23 infants were mixed-fed.
In bivariate analysis, fLBF at 30 weeks gestation was associated significantly and positively with newborn total fat mass (r¼0.397; P¼.001) and body fat percentage (r¼0.369; P¼.004; Figure 1 ) but not with lean mass (r¼0.100; P¼.441) or birthweight percentile (r¼0.132; P¼.306). The correlation between fLBF and newborn body fat percentage was particularly pronounced among newborn infants of mothers with ppBMI <25 kg/m 2 (r¼0.456; P¼.005), compared with newborns of mothers with ppBMI !25 kg/m 2 (r¼0.299; P¼.261; Figure 2) .
Estimates from the multiple regression model that associated fLBF with newborn body fat percentage after covariate adjustment are presented in Table 3 . FLBF independently explained 13.5% of the variance in newborn body fat percentage (partial correlation coefficient, 0.368; P¼.004). Each 50-mL/ min increase of fLBF (range, 14.1e168.0 mL/min) was associated linearly with a 2.6% higher newborn body fat percentage. Among newborn infants of mothers with ppBMI <25 kg/ m 2 , fLBF explained 24.4% of the variance in newborn body fat percentage (partial correlation coefficient, 0.494, p¼.003). This relationship remained statistically significant after fLBF was corrected for AC, which suggests that the observed effect is not a function of fetal liver size ( Table 4 ). The association between fLBF and newborn body fat percentage was not significant among overweight/obese mothers (ppBMI !25 kg/m 2 ). Finally, because gestational diabetes may influence fetal size and body composition over and beyond maternal ppBMI, 49 we repeated all analyses after excluding the 3 subjects with gestational diabetes. There was, however, no appreciable change in the significance and magnitude of the above-described effects of fLBF on newborn adiposity.
Comment
To the best of our knowledge, this is the first study to demonstrate a prospective association of fLBF to be assessed before the period of maximal fetal fat deposition (ie, the third trimester of pregnancy) 30,31 with newborn adiposity. Our principal findings are that fLBF in the early third trimester explains a substantial proportion of the variance in newborn adiposity and that this relationship is more pronounced among nonoverweight/nonobese mothers (ppBMI <25 kg/m 2 ). After the effects of parity, infant sex, and postnatal age at DXA were accounted for, fLBF at 30 weeks gestation explained 13.5% of the variation in newborn body fat percentage. This effect was independent of fetal AC, which suggests that the effect of fLBF was not simply a consequence of greater fetal liver size. Original Research OBSTETRICS
ajog.org
Thus, our finding replicates and extends the earlier observation that fLBF at 36 weeks gestation is positively associated with newborn fat mass. 21 The fetal liver is one of the primary sites of de novo synthesis of essential nutrients required for adipose tissue accretion. The importance of fetal hepatic de novo lipogenesis in creating the subcutaneous energy reservoir is well established. [50] [51] [52] Fatty acid synthesis is mediated by lipogenic enzymes that include acetylCoA carboxylase, fatty acid synthase, and glucose-6-phosphate dehydrogenase, whose activity is high in fetal life. 53 The production of growth factors and hormones that are implicated in the regulation of fetal growth (eg, hepatocyte growth factors, insulin-like growth factors, leptin) is mediated by processes that occur within the liver. [54] [55] [56] For example, in fetal sheep, experimental manipulations that increase fLBF induce hepatic growth factor synthesis and soft tissue accretion. 57 The association between fLBF and newborn body fat percentage was particularly pronounced in newborn infants of nonoverweight/nonobese mothers in whom fLBF explained 24.4% of the variation in newborn body fat percentage. This finding is consistent with that from an earlier study that reported a stronger association between fLBF and newborn adiposity in the offspring of thinner mothers. 21 In overweight/obese mothers, obesity-related elevations of maternal triglycerides, fatty acids, and placental fatty acid transporters result in higher fetal triglycerides that, in turn, are a major source of fetal fat deposition. 29, 58 Some strengths of our study include the prospective ascertainment of fLBF before the period of maximal fetal adipose tissue accretion 30,31 and the direct ascertainment of newborn body composition. Unlike many of the previous studies of newborn adiposity that have relied on proxy indicators such as ponderal index (that provide indirect estimates of fat mass and correlate only moderately with measures of adiposity 59 ), we used newborn DXA imaging to obtain reliable measures of newborn body composition directly. 44, 60 In terms of potential limitations, greater measurement error in fetal ultrasonography may occur in overweight/obese women because of the thicker maternal subcutaneous fat layer and lower resolution of the ultrasound images. However, in our study, the reliability estimates of Doppler flow velocimetry and vessel diameter were comparable across the nonoverweight/ nonobese and overweight/obese groups. We also note that the fetal liver receives venous blood flow not only from the UV but also from the portal vein; this flow was not evaluated in the present study. Portal vein flow, however, accounts for only a small proportion of fLBF and is not believed to be a source of nutrient substrate from the placenta. 61 We used fetal AC as a proxy measure of fetal liver volume. Direct measurement of fetal liver volume measurement with 3-dimensional ultrasonography 62 might add precision, and this represents a future research direction. As noted earlier, we performed the neonatal DXA scan at approximately 1 month postnatal age to avoid potential artifacts related to the rapid fluid shifts that are known to occur in the first weeks after birth. Because neonatal fat mass was not estimated immediately after birth, it is possible that postnatal factors such as postnatal age at scan and type of feeding may have exerted an additional influence on the fat mass measure. However, our analysis did adjust for the effects of these variables (ie, postnatal age at DXA scan and mode of infant feeding).
A question of interest and future direction of this research is the elucidation of the determinants of variation in fLBF that include, but are not limited to, measures of maternal nutritional and metabolic state (eg, essential fatty acids, essential amino acids) that have been shown to affect infant body composition. 27, 63, 64 It is also possible that measures of fLBF that use quantitative 3-dimensional power Doppler ultrasound scanning may improve precision; this too warrants future investigation. 65 In conclusion, fLBF at 30 weeks gestation was associated positively with newborn adiposity. Our findings support and extend the formulation of Godfrey et al 21 regarding fLBF as a putative mechanism underlying fetal adaptations to energy substrate availability. The present finding provides further evidence that variation in newborn adiposity may be conditioned, in part, by developmental processes during intrauterine life. These findings potentially may also provide a basis for the development of biomarkers and intervention strategies during pregnancy that may modify newborn adiposity and subsequent obesity and metabolic dysfunction risk.
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